HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors

Journal of Biomedical Science

Volumn 5, Issue 5, 1998, Pages 321-331

  Posch, Phillip E ^a   Borrego, Francisco ^b   Brooks, Andrew G ^a   Coligan, John E ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CD94; HLA E; Major histocompatibility complex, class I; Natural killer cells; NKG2

Indexed keywords

CD94 ANTIGEN; CELL RECEPTOR; HLA ANTIGEN; HLA E ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; COVALENT BOND; GLYCOSYLATION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR INTERACTION; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

EID: 0031717783     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253442     Document Type: Review

References (102)

1. Acevedo A, Aramburu J, Lopez J, Fernandez-Herrera J, Fernandez-Ranada JM, Lopez-Botet M. Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: Expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates. J Invest Dermatol 4:659-666;1991.
2. Adamkiewicz TV, McSherry C, Bach FH, Houchins JP. Natural killer lectin-like receptors have divergent carboxy-termini, distinct from C-type lectins. Immunogenetics 39:218;1994.
3. Aldrich CJ, DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J. Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79:649-658;1994.
4. Alvarez M, Martinez-Laso J, Varela P, Diaz-Campos N, Gomez-Casado E, Vargas-Alarcon G, Garcia-Torre C, Arnaiz-Villena A. High polymorphism of Mhc-E locus in non-human pnmates: Alleles with identical exon 2 and 3 are found in two different species. Tissue Antigens 49:160-167;1997.
5. + T lymphocytes. I. Inhibition of the IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol 144:3238-3247;1990.
6. + T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol 147:714-721;1991.
7. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 183:645-650;1996.
8. Biassoni R, Pessino A, Malaspina A, Cantoni C, Bottino C, Sivori S, Moretta L, Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol 27:3095-3099;1997.
9. Bijlmkers M, Ptoegh H. Putting together an MHC class I moiecule. Curr Opin Immunol 5:21-26;1993.
10. Biron CA. Activation and function of natural killer cell response during viral infections Curr Opin Immunol 9:24-34;1997.
11. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731-1735;1989.
12. Bodtner JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMTh, Strominger JL, Svejgaard A, Terasaki PI. Nomenclature for factors of the HLA system. Tissue Antigens 46:1-18;1995.
13. Borges L, Hsu M-L, Fanger N, Kubin M. Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159:5192-5196;1997.
14. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187:813-818;1998.
15. Boyson JE, McAdam SN, Galltmore A, Golos TG, Liu X, Gotch FM, Hughes AL, Watkins DI. The MHC-E locus in macaques is polymorphic and is conserved between macaques and humans Immunogenetics 41:59-68;1995.
16. Braud V, Jones EY, McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 27:1164-1169;1997.
17. Braud VM, Allan DSJ, Wilson D, McMichael AJ TAP- and tapasin-dependent HIA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 8:1-10;1997.
18. Braud VM, Allan DSJ, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795-799;1998.
19. Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE. NKG2A completed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med 185:795-800;1997.
20. Brumbaugh KM, Perez-Viliar JJ, Dick CJ, Schoon RA, Lopez-Botet M, Leibson PJ. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J Immunol 157:2804-2812;1996.
21. Burshtyn DM, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P, Long EO. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77-85;1996.
22. Cantoni C, Biassoni R, Pende D, Sivori S, Accame L, Pareti L, Semenzato G, Moretta L, Moretta A, Bottino C. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of tte NKG2-C gene. Eur J Immunol 28:327-338;1998.
23. Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, Rodriguez A, Perez-Villar JJ, Moretta L, Moretta A, Lopez-Botet M. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 27:563-567;1997.
24. Cella M, Döhring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M. A novel inhibitory receptor (ILT3) expressed in monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185:1743-1751;1997.
25. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips J, Lanier LL. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 25:2433-2437;1995.
26. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260:1121-1124;1993.
27. Colonna M, Navano F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809-1818;1997
28. Colonna M, Samandis J, Cella M, Angman L, Alien RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and neoclassical MHC class I molecules. J Immunol 160:3096-3100;1998.
29. Connolly DJ, Cottenll LA, Hederer RA, Thorpe CJ, Travers PJ, McVey JH, Dyson PJ, Robinson PJ. A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J Immunol 151:6089-6098;1993.
30. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu H-L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-282;1997.
31. Döhnng C, Scheidegger D, Samaridis J, Cella M, Colonna M A human killer inhibitory receptor specific for HLA-A. J Immunol 156:3098-3101;1996.
32. Diehl M, Münz C, Kedholz W, Stevanovi S, Holmes N, Loke YW, Rammensee H-G. Non-classical HLA-G molecules are classical peptide presenters. Curr Biol 6:305-314;1996.
33. Dissen E, Berg SF, Westgaard IH, Fossum S. Molecular characterization of a gene in the rat homologous to CD94. Eur J Immunol 27:2080-2086;1997.
34. Drean EL, Vely F, Olcese L, Cambiaggi A, Guia S, Krystal G, Gervois N, Moretta A, Jotereau F, Vivier E. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHIP-1 and SHIP-2 protein-tyrosine phosphatases. Eur J Immunol 28:264-276;1998.
35. Ellis SA, Sargent IL, Redman WG, McMichael AJ. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 59:595-601;1986.
36. Fry AM, Lanier LL, Weiss A. Paosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative smgaling and for association with protein tyrosine phosphatase IC. J Exp Med 184:295-300;1996.
37. Geraghty DE. Structure of the HLA class I region and expression of its resident genes. Curr Opin Immunol 5:3-7;1993.
38. Germain R. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-299;1994.
39. Gomez-Casado E, Martinez-Laso J, Vargas-Alarcon G, Varela P, Diaz-Campos N, Alvarez M, Alegre R, Amaiz-Villena A. Description of a new HLA-E (E*01031) allele and its frequency in the Spanish population. Hum Immunol 54:69-73;1997.
40. Grimsley C, Ober C. Population genetic studies of HLA-E: Evidence for selection. Hum Immunol 52:33-40;1997.
41. Houchins JP, Yabe T, McSherry C, Miyokawa N, Bach FH. Isolation and characterization of NK cell or NK/T cell-specific cDNA clones. J Mol Cell Immunol 4:295-306;1990.
42. Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 173:1017-1020;1991.
43. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 158:3603-3609;1997.
44. Houlihan JM, Biro PA, Harper HM, Jenkmson HJ, Holmes CH. The human amnion is a site of MHC class Ib expression: Evidence for the expression of HLA-E and HLA-G. J Immunol 154:5665-5674;1995.
45. Jackson MR, Cohen Doyle MF, Peterson PA, Williams DB, Regulation of MHC class I transport by the molecular chaperone. calnexin (p88, IP90). Science 263:384-387;1994.
46. Knapp LA, Cadavid LF, Watkins DI. The MHC-E locus is the most well conserved of all known primate class I histocompatibility genes. J Immunol 160:189-196;1998.
47. Koller BH, Geraghty DE, DeMars R, Orr HT. HLA-E: A novel HLA class I gene expressed in resting T-lymphocytes. J Immunol 141:897-904:1988.
48. Lanier LL. The role of natural killer cells in transplantation. Curr Opin Immunol 7:626-631;1995.
49. Lanier LL. Natural killer cells: From no receptors to too many. Immunity 6:371-378;1997.
50. Lanier LL. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 92:705-707;1998.
51. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703-707;1998.
52. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741-4745;1996.
53. Litwin V, Gumperez J, Parham P, Phillips JH, Lanier LL. Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med 178:1321-1336;1993.
54. Ljunggren H-G, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11:237-244;1990.
55. Long EO, Wagtmann N. Natural killer cell receptors. Curr Opin Immunol 9:344-350;1997.
56. Long EO, Burshtyn DN, Clark WP, Peruzzi M, Rajagopalan S, Rojo S, Wagtmann N, Winter CC. Killer cell inhibitory receptors: Diversity, specificity, and function. Immunol Rev 155:135-144;1997.
57. Madden DR. The three-dimensional structure of peptide-MHC complex. Annu Rev Immunol 133:587-622;1995.
58. Malnati M, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO. Peptide specificity in the recognition of MHC class 1 by natural killer cell clones. Science 267:1016-1018;1995.
59. Mandelboim O, Wilson SB, Vales-Gomez M, Revburn HT, Strominger JL. Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci USA 94:4604-4609;1997.
60. McMaster MT, Librach CL, Zhou Y, Lim KH, Janatpour MJ, DeMars R, Kovats S, Damsky C, Fisher SJ. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 154:3771-3778;1995.
61. Mingan MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Benone S, Moretta A, Moretta L. Interleukin-15-mduced maturation of human natural killer cells from early thymic precursors: Selective expression of CD94/ NTCG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol 27:1374-1380;1997.
62. Mingan MC, Morecta A, Moretta L. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses. Immunol Today 19:153-157;1998.
63. Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigenor alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA 95:1172-1177;1998.
64. Mizuno S, Trapani JA, Koller BH, Dupont B, Yang SY. Isolation and nucleotide sequence of a cDNA clone encoding a novel HLA class I gene. J Immunol 140:4024-4030;1988
65. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, Lopez-Botet M, Moretta L. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 180:545-555;1994.
66. Nossner E, Parham P. Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J Exp Med 181:327-337;1995.
67. O'Callaghan CA, Tormo J, Willcox BE, Braud VM, Jakobsen BK, Stuart DI, McMichael AJ, Bell JI, Jones EY. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell 1:531-541;1998.
68. Ohya K, Kondo K, Mizuno S. Polymorphism in the human class I MHC locus HLA-E in Japanese. Immunogenetics 32:205-209;1990.
69. Ortmann B, Androlewicz MJ, Cresswell P. MHC class I/β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864-867;1994.
70. Parham P, Lomen CE, Lawlor DA, Ways JP, Holmes N, Coppin HL, Salter RD, Wan AM, Ennis PD. The nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci USA 85:4005-4009:1988.
71. Parham P, Lawlor DA, Salter RD, Lomen CE, Ennis PD. Diversity and diversification of HLA-A. B, C alleles. J Immunol 142:3937-3950;1989.
72. Peace Brewer AL, Tussey LG, Matsui M, LI G, Quinn DG, Frelinger JA. A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 4:505-514;1996
73. Pende D, Biassoni R, Caatoni C, Verdiant S, Falco M, di Donate C, Accame L, Bortino C, Moretta A, Moretta L. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 184:505-518;1996.
74. Pérez-Villar JJ, Melero I, Rodriguez A. Carretero M, Aramburu J, Sivon S, Orengo AM, Moretta A, Lopez-Botet M. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 154:5779-5788;1995.
75. Pérez-Villar JJ, Carretero M, Navarro F. Melero I, Rodriguez A, Bottino C, Moretta A, Lopez-Botet M. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J Immunol 57:5367-5374;1996.
76. Phillips JH, Chang C, Mattson J, Gumperez JE, Parhara P, Lanier LL. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B and HLA-C allotypes. Immunity 5:163-172;1996.
77. Ploegh HL. Viral strategies of immune evasion. Science 280:248-253;1998.
78. Plougastel B, Trowsdale J. Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes. Eur J Immunol 27:2835-2839;1997.
79. Raulet DH, Held W, Correa I, Dorfman J, Wu M-F, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 155:41-52;1998.
80. Reybum HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL. The class IMHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514-517;1997.
81. Rubio G, Aramburu J, Ontanon J, Lopez-Botet M, Aparicio P. A novel functional cell surface dimer (Kp43) serves as accessory molecule for the activation of a subset of human gamma delta T cells. J Immunol 151:1312-1321;1993.
82. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasm, in the interaction of MHC class I molecules with TAP. Immunity 5:103-114;1995.
83. Samaridis J, Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 27:660-665;1997.
84. Shawar SM, Vyas JV, Rodgers JR, Rich RR. Antigen presentation by major histocompatibility complex class Ib molecules Annu Rev Immunol 12:839-880;1994.
85. Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Morena L, Moretta A. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 26:2487-2492;1996.
86. Soloski MJ, DeCloux A, Aldrich CJ, Forman J. Structural and functional characteristics of the class IB molecule, Qa-1. Immunol Rev 147:67-89;1995.
87. 2-microglobulin: Major histocompanbility complex class 1 heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide. J Exp Med 180:2163-2171;1994.
88. Suh W, Cohen-Doyle MF, Fruh K, Wang K, Peterson PA, Williams DB. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322-1326;1994.
89. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 7:601-624;1989.
90. Trinchieri G. Biology of natural killer cells. Adv Immunol 47:187-376;1989.
91. Uhrberg M, Valiante MM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity 7:753-763;1997.
92. Ulbrecht M, Honka T, Person S, Johnson JP, Weiss EH. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol 149:2945-2953;1992.
93. Ulbrecht M, Kellermann J, Johnson JP, Weiss EH. Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: Evidence for inefficient peptide binding. J Exp Med 176:1083-1090;1992.
94. Ulbrecht M, Modrow S, Srivastava R, Peterson PA, Weiss EH. Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation. J Immunol 160:4375-4385;1998.
95. Valiante NM, Uhrberg M, Shilling HG, Lienen-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 6:739-751;1997.
96. Vance RE, Tanamaki DM, Hanke T, Raulet DH. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol 27:3236-3241;1997.
97. Wei X, Orr HT. Differential expression of HLA-E, HLA-F and HLA-G transcripts in human tissue. Hum Immunol 29:131-142;1990.
98. Whiteside TL, Herberman RB. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 7.704-710;1995.
99. Yabe T, McSherry C, Bach FH, Fisch F, Schall RP, Sondell PM, Houchins JP. A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 37:455-460;1993.
100. Yokoyama WM. Hybrid resistance and the Ly-49 family of natural killer cell receptors. J Exp Med 182:273-277;1995.
101. York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Ann Rev Immunol 14:369-396;1996
102. Zappacosta F, Borrego F, Brooks AG, Parker KC, Cohgan JE. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell- mediated lysis. Proc Natl Acad Sci USA 94:6313-6318;1997.